FDA NDC Directory · JSON-LD · Markdown

Besivance

NDC 82260-466 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameBesifloxacin
Labeler / ManufacturerBausch & Lomb Americas Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022308
Dosage form / routeSUSPENSION · OPHTHALMIC
Active ingredientsBESIFLOXACIN (6 mg/mL)
Marketing started20260109
Package count1

External sources

Source: openFDA. Public-domain (CC0).